EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Special Issue “Metformin: Mechanism and Application 2023”

Agnieszka Śliwińska iD

Pharmaceuticals · 11.08.2026 · 19 (8) · 1263

DOI: 10.3390/ph19081263 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 11.08.2026. Verfasst von Agnieszka Śliwińska. Beteiligte Einrichtung: Department of Nucleic Acid Biochemistry, Medical University of Lodz, 92-213 Lodz, Poland. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin remains the cornerstone of pharmacological therapy for type 2 diabetes mellitus (T2DM) [...]

Autor:innen und Institutionen

  • Department of Nucleic Acid Biochemistry, Medical University of Lodz, 92-213 Lodz, Poland.

ORCID-Profile: Agnieszka Śliwińska

Zitieren

APA

Śliwińska, A. (2026). Special Issue “Metformin: Mechanism and Application 2023”. Pharmaceuticals, 19(8), 1263. https://doi.org/10.3390/ph19081263

Vancouver

Śliwińska A. Special Issue “Metformin: Mechanism and Application 2023”. Pharmaceuticals. 2026;19(8):1263. doi:10.3390/ph19081263

BibTeX
@article{liwiska2026,
  author = {Śliwińska, Agnieszka},
  title = {Special Issue “Metformin: Mechanism and Application 2023”},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {8},
  pages = {1263},
  doi = {10.3390/ph19081263}
}
Kostenlos starten →